Exploration of Drug Science

Declarations

Acknowledgments

The author thanks Dr. Rosario González-Muñiz from IQM-CSIC for helpful advice and discussions.

Author contributions

DNV: Conceptualization, Investigation, Writing—original draft, Writing—review & editing.

Conflicts of interest

The author declares that he has no conflicts of interest.

Ethical approval

Not applicable.

Consent to participate

Not applicable.

Consent to publication

Not applicable.

Availability of data and materials

Structural data shown in the Figures of this review article was obtained from publicly available repositories: RCSB Protein Data Bank (www.rcsb.org) and the Cambridge Structural Database (CSD) from the Cambridge Crystallographic Data Centre (www.ccdc.cam.ac.uk). These publicly available repositories allow direct use of the Figure it provides. CIF files were analyzed with Mercury and the images were created with PyMOL (https://pymol.org/pymol.html).

Funding

This work is supported by a ComFuturo fellowship from the Fundación General CSIC (European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement [101034263]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright

References

Sun PD, Foster CE, Boyington JC. Overview of protein structural and functional folds. Curr Protoc Protein Sci. 2004;35:17.1.1–189. [DOI] [PubMed] [PMC]

Stites WE. Protein–protein interactions: interface structure, binding thermodynamics, and mutational analysis. Chem Rev. 1997;97:1233–50. [DOI]

Berg T. Modulation of protein–protein interactions with small organic molecules. Angew Chem Int Ed Engl. 2003;42:2462–81. [DOI] [PubMed]

Azzarito V, Long K, Murphy NS, Wilson A. Inhibition of α-helix-mediated protein–protein interactions using designed molecules. Nat Chem. 2013;5:161–73. [DOI] [PubMed]

de Brevern AG. Extension of the classical classification of β-turns. Sci Rep. 2016;6:33191. [DOI] [PubMed] [PMC]

Loughlin WA, Tyndall JDA, Glenn MP, Fairlie DP. Beta-strand mimetics. Chem Rev. 2004;104:6085–118. [DOI] [PubMed]

DuPai CD, Davies BW, Wilke CO. A systematic analysis of the beta hairpin motif in the Protein Data Bank. Protein Sci. 2021;30:613–23. [DOI] [PubMed] [PMC]

Kumar P, Paterson NG, Clayden J, Woolfson DN. De novo design of discrete, stable 3₁₀-helix peptide assemblies. Nature. 2022;607:387–92. [DOI] [PubMed]

Toniolo C, Benedetti E. The polypeptide 3₁₀-helix. Trends Biochem Sci. 1991;16:350–3. [DOI] [PubMed]

10.

Barlow DJ, Thornton JM. Helix geometry in proteins. J Mol Biol. 1988;201:601–19. [DOI] [PubMed]

11.

Kumar P, Bansal M. Dissecting π-helices: sequence, structure and function. FEBS J. 2015;282:4415–32. [DOI] [PubMed]

12.

Taylor HS. Large molecules through atomic spectacles. Proc Am Phil Soc. 1941;85:1–12.

13.

Pauling L, Corey RB, Branson HR. The structure of proteins: two hydrogen-bonded helical configurations of the polypeptide chain. Proc Natl Acad Sci U S A. 1951;37:205–11. [DOI] [PubMed] [PMC]

14.

Shamala N, Nagaraj R, Balaram P. The 3₁₀ helical conformation of a pentapeptide containing α-aminoisobutyric acid (Aib): X-ray crystal structure of Tos–(Aib)₅–OMe. J Chem Soc Chem Commun. 1978:996–7. [DOI]

15.

Gessmann R, Brückner H, Petratos K. Three complete turns of a 3₁₀-helix at atomic resolution: the crystal structure of Z-(Aib)₁₁-OtBu. J Pept Sci. 2003;9:753–62. [DOI] [PubMed]

16.

Crisma M, Formaggio F, Moretto A, Toniolo C. Peptide helices based on α‐amino acids. Biopolymers. 2006;84:3–12. [DOI] [PubMed]

17.

Koch O, Bocola M, Klebe G. Cooperative effects in hydrogen-bonding of protein secondary structure elements: a systematic analysis of crystal data using Secbase. Proteins. 2005;61:310–7. [DOI] [PubMed]

18.

Kitagawa K, Morita T, Kimura S. A helical molecule that exhibits two lengths in response to an applied potential. Angew Chem Int Ed Engl. 2005;44:6330–3. [DOI] [PubMed]

19.

Karpen ME, de Haseth PL, Neet KE. Differences in the amino acid distributions of 3₁₀-helices and α-helices. Protein Sci. 1992;1:1333–42. [DOI] [PubMed] [PMC]

20.

Pal L, Basu G, Chakrabarti P. Variants of 3₁₀-helices in proteins. Proteins. 2002;48:571–9. [DOI]

21.

Coskuner‑Weber O, Caglayan SI. Secondary structure dependence on simulation techniques and force field parameters: from disordered to ordered proteins. Biophys Rev. 2021;13:1173–8. [DOI] [PubMed] [PMC]

22.

Patapati KK, Glykos NM. Three force fields’ views of the 3₁₀ helix. Biophys J. 2011;101:1766–71. [DOI] [PubMed] [PMC]

23.

Stevens AO, He Y. Benchmarking the accuracy of AlphaFold 2 in loop structure prediction. Biomolecules. 2022;12:985. [DOI] [PubMed] [PMC]

24.

Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 1983;22:2577–637. [DOI] [PubMed]

25.

Frishman D, Argos P. Knowledge-based protein secondary structure assignment. Proteins. 1995;23:566–79. [DOI] [PubMed]

26.

Krimm S, Bandekar J. Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins. Adv Protein Chem. 1986;38:181–364. [DOI] [PubMed]

27.

Yang H, Yang S, Kong J, Dong A, Yu S. Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy. Nat Protoc. 2015;10:382–96. [DOI] [PubMed]

28.

Manning MC, Woody RW. Theoretical CD studies of polypeptide helices: examination of important electronic and geometric factors. Biopolymers. 1991;31:569–86. [DOI] [PubMed]

29.

Toniolo C, Polese A, Formaggio F, Crisma M, Kamphuis J. Circular dichroism spectrum of a peptide 3₁₀-helix. J Am Chem Soc. 1996;118:2744–5. [DOI]

30.

Silva RA, Yasui SC, Kubelka J, Formaggio F, Crisma M, Toniolo C, et al. Discriminating 3₁₀- from α-helices: vibrational and electronic CD and IR absorption study of related Aib-containing oligopeptides. Biopolymers. 2002;65:229–43. [DOI] [PubMed]

31.

Toniolo C, Formaggio F, Tognon S, Broxterman QB, Kaptein B, Huang R, et al. The complete chirospectroscopic signature of the peptide 3₁₀-helix in aqueous solution. Biopolymers. 2004;75:32–45. [DOI] [PubMed]

32.

Wüthrich K. NMR of proteins and nucleic acids. New York: Wiley; 1985.

33.

Millhauser GL, Stenland CJ, Hanson P, Bolin KA, van de Ven FJM. Estimating the relative populations of 3₁₀-helix and α-helix in Ala-rich peptides: a hydrogen exchange and high field NMR study. J Mol Biol. 1997;267:963–74. [DOI] [PubMed]

34.

Gratias R, Konat R, Kessler H, Crisma M, Valle G, Polese A, et al. First step toward the quantitative identification of peptide 3₁₀-helix conformation with NMR spectroscopy: NMR and X-ray diffraction structural analysis of a fully-developed 3₁₀-helical peptide standard. J Am Chem Soc. 1998;120:4763–70. [DOI]

35.

Mammi S, Rainaldi M, Bellanda M, Schievano E, Peggion E, Broxterman QB, et al. Concomitant occurrence of peptide 3₁₀- and α-helices probed by NMR. J Am Chem Soc. 2000;122:11735–6. [DOI]

36.

Shabestari MH, van Son M, Moretto A, Crisma M, Toniolo C, Huber M. Conformation and EPR characterization of rigid, 3₁₀-helical peptides with TOAC spin labels: models for short distances. Biopolymers. 2014;102:244–51. [DOI] [PubMed]

37.

Millhauser GL. Views of helical peptides: a proposal for the position of 3₁₀-helix along the thermodynamic folding pathway. Biochemistry. 1995;34:3873–7. Erratum in: Biochemistry. 1995;34:10318. [DOI] [PubMed]

38.

Bolin KA, Millhauser GL. α and 3₁₀: the split personality of polypeptide helices. Acc Chem Res. 1999;32:1027–33. [DOI]

39.

Karle IL, Balaram P. Structural characteristics of α-helical peptide molecules containing Aib residues. Biochemistry. 1990;29:6747–56. [DOI] [PubMed]

40.

Miick SM, Martinez GV, Fiori WR, Todd AP, Millhauser GL. Short alanine-based peptides may form 3₁₀-helices and not α-helices in aqueous solution. Nature. 1992;359:653–5. Erratum in: Nature. 1995;377:257. [DOI] [PubMed]

41.

Fiori WR, Miick SM, Millhauser GL. Increasing sequence length favors α-helix over 3₁₀-helix in alanine-based peptides: evidence for a length-dependent structural transition. Biochemistry. 1993;32:11957–62. [DOI] [PubMed]

42.

Hoang HN, Hill TA, Ruiz-Gómez G, Diness F, Mason JM, Wu C, et al. Twists or turns: stabilising alpha vs. beta turns in tetrapeptides. Chem Sci. 2019;10:10595–600. [DOI] [PubMed] [PMC]

43.

Wieczorek R, Dannenberg JJ. H-bonding cooperativity and energetics of α-helix formation of five 17-amino acid peptides. J Am Chem Soc. 2003;125:8124–9. [DOI] [PubMed]

44.

Hua S, Xu L, Li W, Li S. Cooperativity in long α- and 3₁₀-helical polyalanines: both electrostatic and van der Waals interactions are essential. J Phys Chem B. 2011;115:11462–9. [DOI] [PubMed]

45.

Wieczorek R, Dannenberg JJ. Comparison of fully optimized α- and 3₁₀-helices with extended β-strands. An ONIOM density functional theory study. J Am Chem Soc. 2004;126:14198–205. [DOI] [PubMed]

46.

Otoda K, Kitagawa Y, Kimura S, Imanishi Y. Chain length dependent transition of 3₁₀- to α-helix of Boc-(Ala-Aib)_n-OMe. Biopolymers. 1993;33:1337–45. [DOI]

47.

Karle IL, Sukumar M, Balaram P. Parallel packing of alpha-helices in crystals of the zervamicin IIA analog Boc-Trp-Ile-Ala-Aib-Ile-Val-Aib-Leu-Aib-Pro-OMe.2H₂O. Proc Natl Acad Sci U S A. 1986;83:9284–8. [DOI] [PubMed] [PMC]

48.

Karle IL, Flippen-Anderson JL, Sukumar M, Balaram P. Monoclinic polymorph of Boc-Trp-Ile-Ala-Aib-Ile-Val-Aib-Leu-Aib-Pro-OMe(anhydrous). Int J Pept Protein Res. 1988;31:567–76. [DOI] [PubMed]

49.

Singh Y, Sharpe PC, Hoang HN, Lucke AJ, McDowall AW, Bottomley SP, et al. Amyloid formation from an α-helix peptide bundle is seeded by 3₁₀-helix aggregates. Chemistry. 2011;17:151–60. [DOI] [PubMed]

50.

Hiew SH, Mohanram H, Ning L, Guo J, Sánchez-Ferrer A, Shi X, et al. A short peptide hydrogel with high stiffness induced by 3₁₀-helices to β-sheet transition in water. Adv Sci. 2019;6:1901173. [DOI] [PubMed] [PMC]

51.

Sorin EJ, Rhee YM, Shirts MR, Pande VS. The solvation interface is a determining factor in peptide conformational preferences. J Mol Biol. 2006;356:248–56. [DOI] [PubMed]

52.

Bellanda M, Mammi S, Geremia S, Demitri N, Randaccio L, Broxterman QB, et al. Solvent polarity controls the helical conformation of short peptides rich in C^α-tetrasubstituted amino acids. Chemistry. 2007;13:407–16. [DOI] [PubMed]

53.

Xiong K, Asciutto EK, Madura JD, Asher SA. Salt dependence of an α-helical peptide folding energy landscapes. Biochemistry. 2009;48:10818–26. [DOI] [PubMed] [PMC]

54.

Eliezer D, Yao J, Dyson HJ, Wright PE. Structural and dynamic characterization of partially folded states of apomyoglobin and implications for protein folding. Nat Struct Biol. 1998;5:148–55. [DOI] [PubMed]

55.

Sun JK, Doig AJ. Addition of side-chain interactions to 3₁₀-helix/coil and α-helix/3₁₀-helix/coil theory. Protein Sci. 1998;7:2374–83. [DOI] [PubMed] [PMC]

56.

Tirado-Rives J, Jorgensen WL. Molecular dynamics simulations of the unfolding of an α-helical analogue of ribonuclease A S-peptide in water. Biochemistry. 1991;30:3864–71. [DOI] [PubMed]

57.

Daggett V, Levitt M. Molecular dynamics simulations of helix denaturation. J Mol Biol. 1992;233:1121–38. [DOI] [PubMed]

58.

Takano M, Yamato T, Higo J, Suyama A, Nagayama K. Molecular dynamics of a 15-residue poly(_L-alanine) in water: helix formation and energetics. J Am Chem Soc. 1999;121:605–12. [DOI]

59.

Chipot C, Pohorille A. Folding and translocation of the undecamer of poly-_L-leucine across the water–hexane interface. A molecular dynamics study. J Am Chem Soc. 1998;120:11912–24. [DOI] [PubMed]

60.

Sheinerman FB, Brooks CL III. 3₁₀ Helices in peptides and proteins as studied by modified Zimm–Bragg theory. J Am Chem Soc. 1995;117:10098–103. [DOI]

61.

Rohl CA, Doig AJ. Models for the 3₁₀-helix/coil, π-helix/coil, and α-helix/3₁₀-helix/coil transitions in isolated peptides. Protein Sci. 1996;5:1687–96. [DOI] [PubMed] [PMC]

62.

Nellas RB, Johnson QR, Shen T. Solvent-induced α- to 3₁₀-helix transition of an amphiphilic peptide. Biochemistry. 2013;52:7137–44. [DOI] [PubMed]

63.

Dehner A, Planker E, Gemmecker G, Broxterman QB, Bisson W, Formaggio F, et al. Solution structure, dimerization, and dynamics of a lipophilic α/3₁₀-helical, C^α-methylated peptide. implications for folding of membrane proteins. J Am Chem Soc. 2001;123:6678–86. [DOI] [PubMed]

64.

Chamberlain AK, Faham S, Yohannan S, Bowie JU. Construction of helix-bundle membrane proteins. Adv Protein Chem. 2003;63:19–46. [DOI] [PubMed]

65.

Daniel JF, Filho ER. Peptaibols of Trichoderma. Nat Prod Rep. 2007;24:1128–41. [DOI] [PubMed]

66.

Hou X, Sun R, Feng Y, Zhang R, Zhu T, Che Q, et al. Peptaibols: diversity, bioactivity, and biosynthesis. Eng Microbiol. 2022;2:100026. [DOI]

67.

Duclohier H. Antimicrobial peptides and peptaibols, substitutes for conventional antibiotics. Curr Pharm Des. 2010;16:3212–23. [DOI] [PubMed]

68.

Sansom MS. Alamethicin and related peptaibols — model ion channels. Eur Biophys J Biophy. 1993;22:105–24. [DOI] [PubMed]

69.

Bobone S, Gerelli Y, De Zotti M, Bocchinfuso G, Farrotti A, Orioni B, et al. Membrane thickness and the mechanism of action of the short peptaibol trichogin GA IV. Biochim Biophys Acta. 2013;1828:1013–24. [DOI] [PubMed]

70.

Gobbo M, Poloni C, De Zotti M, Peggion C, Biondi B, Ballano G, et al. Synthesis, preferred conformation, and membrane activity of medium-length peptaibiotics: tylopeptin B. Chem Biol Drug Des. 2010;75:169–81. [DOI] [PubMed]

71.

Aubry A, Bayeul D, Brückner H, Schiemann N, Benedetti E. The crystal state conformation of Aib-rich segments of peptaibol antibiotics. J Pept Sci. 1998;4:502–10. [DOI] [PubMed]

72.

Huelsmann H, Heinze S, Ritzau M, Schlegel B, Gräfe U. Isolation and structure of peptaibolin, a new peptaibol from Sepedonium strains. J Antibiot. 1998;51:1055–8. [DOI] [PubMed]

73.

Crisma M, Barazza A, Formaggio F, Kaptein B, Broxterman QB, Kamphuis J, et al. Peptaibolin: synthesis, 3D-structure, and membrane modifying properties of the natural antibiotic and selected analogues. Tetrahedron. 2001;57:2813–25. [DOI]

74.

Auvin-Guette C, Rebuffat S, Prigent Y, Bodo B. Trichogin A IV, an 11-residue lipopeptaibol from Trichoderma longibrachiatum. J Am Chem Soc. 1992;114:2170–4. [DOI]

75.

Peggion C, Formaggio F, Crisma M, Epand RF, Epand RM, Toniolo C. Trichogin: a paradigm for lipopeptaibols. J Pept Sci. 2003;9:679–89. [DOI] [PubMed]

76.

Toniolo C, Peggion C, Crisma M, Formaggio F, Shui X, Eggleston DS. Structure determination of racemic trichogin A IV using centrosymmetric crystals. Nat Struct Biol. 1994;1:908–14. [DOI] [PubMed]

77.

Rebuffat S, Goulard C, Bodo B. Antibiotic peptides from Trichoderma harzianum: harzianins HC, proline-rich 14-residue peptaibols. J Chem Soc Perkin Trans 1. 1995:1849–55. [DOI]

78.

Brückner H, Koza A. Solution phase synthesis of the 14-residue peptaibol antibiotic trichovirin I. Amino Acids. 2003;24:311–23. [DOI] [PubMed]

79.

van Bohemen AI, Ruiz N, Zalouk-Vergnoux A, Michaud A, Robiou du Pont T, Druzhinina I, et al. Pentadecaibins I–V: 15-residue peptaibols produced by a marine-derived Trichoderma sp. of the Harzianum clade. J Nat Prod. 2021;84:1271–82. [DOI] [PubMed]

80.

Karle IL, Perozzo MA, Mishra VK, Balaram P. Crystal structure of the channel-forming polypeptide antiamoebin in a membrane-mimetic environment. Proc Natl Acad Sci U S A. 1998;95:5501–4. [DOI] [PubMed] [PMC]

81.

De Zotti M, Biondi B, Peggion C, Park Y, Hahm KS, Formaggio F, et al. Synthesis, preferred conformation, protease stability, and membrane activity of heptaibin, a medium-length peptaibiotic. J Pept Sci. 2011;17:585–94. [DOI] [PubMed]

82.

Karle IL, Flippen-Anderson JL, Agarwalla S, Balaram P. Crystal structure of [Leu1]zervamicin, a membrane ion-channel peptide: implications for gating mechanisms. Proc Natl Acad Sci U S A. 1991;88:5307–11. [DOI] [PubMed] [PMC]

83.

Gessmann R, Axford D, Owen RL, Bruckner H, Petratos K. Four complete turns of a curved 3₁₀-helix at atomic resolution: The crystal structure of the peptaibol trichovirin I-4A in polar environment suggests a transition to α-helix for membrane function. Acta Crystallogr D Biol Crystallogr. 2012;68:109–16. [DOI] [PubMed]

84.

Leitgeb B, Szekeres A, Manczinger L, Vágvölgyi C, Kredics L. The history of alamethicin: a review of the most extensively studied peptaibol. Chem Biodivers. 2007;4:1027–51. [DOI] [PubMed]

85.

Du L, Risinger AL, Mitchell CA, Stamps BW, Pan N, King JB, et al. Novel 22-mer peptaibols isolated from Tolypocladium sp. with potent antitumor activities. Planta Med. 2015;81:PT20. [DOI]

86.

Du L, Risinger AL, Mitchell CA, You J, Stamps BW, Pan N, et al. Unique amalgamation of primary and secondary structural elements transform peptaibols into potent bioactive cell-penetrating peptides. Proc Natl Acad Sci U S A. 2017;114:E8957–66. [DOI] [PubMed] [PMC]

87.

Tani K, Mitsuma T, Hiroaki Y, Kamegawa A, Nishikawa K, Tanimura Y, et al. Mechanism of aquaporin-4’s fast and highly selective water conduction and proton exclusion. J Mol Biol. 2009;389:694–706. [DOI] [PubMed]

88.

Clayton GM, Altieri S, Heginbotham L, Unger VM, Morais-Cabral JH. Structure of the transmembrane regions of bacterial cyclic nucleotide-regulated channel. Proc Natl Acad Sci U S A. 2008;105:1511–5. [DOI] [PubMed] [PMC]

89.

Long SB, Campbell EB, Mackinnon R. Voltage sensor of Kv1.2: structural basis of electromechanical coupling. Science. 2005;309:903–8. [DOI] [PubMed]

90.

Schwaiger CS, Bjelkmar P, Hess B, Lindahl E. 3₁₀-Helix conformation facilitates the transition of a voltage sensor S4 segment toward the down state. Biophys J. 2011;100:1446–54. [DOI] [PubMed] [PMC]

91.

Vieira-Pires RS, Morais-Cabral JH. 3₁₀Helices in channels and other membrane proteins. J Gen Physiol. 2010;136:585–92. [DOI] [PubMed] [PMC]

92.

Pal L, Basu G. Novel protein structural motifs containing two-turn and longer 3₁₀-helices. Protein Eng. 1999;12:811–4. [DOI] [PubMed]

93.

Biron Z, Khare S, Samson AO, Hayek Y, Naider F, Anglister J. A monomeric 3₁₀-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41. Biochemistry. 2002;41:12687–96. [DOI] [PubMed]

94.

Ferreon JC, Ferreon ACM, Li K, Lemon SM. Molecular determinants of TRIF proteolysis mediated by the hepatitis C virus NS3/4A protease. J Biol Chem. 2005;280:20483–92. [DOI] [PubMed]

95.

Huang D, Caflisch A. The roles of the conserved tyrosine in the β2-α2 loop of the prion protein. Prion. 2015;9:412–9. [DOI] [PubMed] [PMC]

96.

Painter CA, Negroni MP, Kellersberger KA, Zavala-Ruiz Z, Evans JE, Stern LJ. Conformational lability in the class II MHC 3₁₀ helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange. Proc Natl Acad Sci U S A. 2011;108:19329–34. [DOI] [PubMed] [PMC]

97.

Zhang M, Zhao J, Yang H, Liu P, Bu Y. 3₁₀-Helical peptide acting as a dual relay for charge-hopping transfer in proteins. J Phys Chem B. 2013;117:6385–93. [DOI] [PubMed]

98.

Park SY, Jeong MS, Han CW, Yu HS, Jang SB. Structural and functional insight into proliferating cell nuclear antigen. J Microbiol Biotechnol. 2016;26:637–47. [DOI] [PubMed]

99.

Ottersbach K, Mclean J, Isaacs NW, Graham GJ. A3₁₀ helical turn is essential for the proliferation-inhibiting properties of macrophage inflammatory protein-1 alpha (CCL3). Blood. 2006;107:1284–91. [DOI] [PubMed]

100.

Wei W, Zheng C, Zhu M, Zhu X, Yang R, Misra S, et al. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII. Sci Rep. 2017;7:45033. [DOI] [PubMed] [PMC]

101.

Hashimoto Y, Kohri K, Kaneko Y, Morisaki H, Kato T, Ikeda K, et al. Critical role for the 3₁₀helix region of p57^Kip2 in cyclin-dependent kinase 2 inhibition and growth suppression. J Biol Chem. 1998;273:16544–50. [DOI] [PubMed]

102.

Patel N, Stengel F, Aebersold R, Gold MG. Molecular basis of AKAP79 regulation by calmodulin. Nat Commun. 2017;8:1681. [DOI] [PubMed] [PMC]

103.

Shinsky SA, Christianson DW. Polyamine deacetylase structure and catalysis: prokaryotic acetylpolyamine amidohydrolase and eukaryotic HDAC10. Biochemistry. 2018;57:3105–14. [DOI] [PubMed] [PMC]

104.

Lam AJ, Rao L, Anazawa Y, Okada K, Chiba K, Dacy M, et al. A highly conserved 3₁₀ helix within the kinesin motor domain is critical for kinesin function and human health. Sci Adv. 2021;7:eabf1002. [DOI] [PubMed] [PMC]

105.

Toniolo C, Crisma M, Bonora GM, Benedetti E, Di Blasio B, Pavone V, et al. Preferred conformation of the terminally blocked (Aib)₁₀ homo-oligopeptide: a long, regular 3₁₀-helix. Biopolymers. 1991;31:129–38. [DOI]

106.

Toniolo C, Crisma M, Formaggio F, Peggion C. Control of peptide conformation by the Thorpe-Ingold effect (C^α-tetrasubstitution). Biopolymers. 2001;60:396–419. [DOI] [PubMed]

107.

Gatto E, Toniolo C, Venanzi M. Peptide self-assembled nanostructures: from models to therapeutic peptides. Nanomaterials. 2022;12:466. [DOI] [PubMed] [PMC]

108.

Caruso M, Placidi E, Gatto E, Mazzuca C, Stella L, Bocchinfuso G, et al. Fibrils or globules? Tuning the morphology of peptide aggregates from helical building blocks. J Phys Chem B. 2013;117:5448–59. [DOI] [PubMed]

109.

Bocchinfuso G, Conflitti P, Raniolo S, Caruso M, Mazzuca C, Gatto E, et al. Aggregation propensity of Aib homo-peptides of different length: an insight from molecular dynamics simulations. J Pept Sci. 2014;20:494–507. [DOI] [PubMed]

110.

Solà J, Helliwell M, Clayden J. Interruption of a 3₁₀-helix by a single Gly residue in a poly-Aib motif: a crystallographic study. Biopolymers. 2011;95:62–9. [DOI] [PubMed]

111.

Brown RA, Marcelli T, De Poli M, Solà J, Clayden J. Induction of unexpected left-handed helicity by an N-terminal L-amino acid in an otherwise achiral peptide chain. Angew Chem Int Ed Engl. 2012;51:1395–9. [DOI] [PubMed]

112.

De Poli M, De Zotti M, Raftery J, Aguilar JA, Morris GA, Clayden J. Left-handed helical preference in an achiral peptide chain is induced by an _L-amino acid in an N-terminal type II β-turn. J Org Chem. 2013;78:2248–55. [DOI] [PubMed]

113.

De Poli M, Byrne L, Brown RA, Solà J, Castellanos A, Boddaert T, et al. Engineering the structure of an N-terminal β-turn to maximize screw-sense preference in achiral helical peptide chains. J Org Chem. 2014;79:4659–75. [DOI] [PubMed]

114.

Inai Y, Ousaka N, Okabe T. Mechanism for the noncovalent chiral domino effect: new paradigm for the chiral role of the N-terminal segment in a 3₁₀-helix. J Am Chem Soc. 2003;125:8151–62. [DOI] [PubMed]

115.

Brown RA, Diemer V, Webb SJ, Clayden J. End-to-end conformational communication through a synthetic purinergic receptor by ligand-induced helicity switching. Nat Chem. 2013;5:853–60. [DOI] [PubMed]

116.

Brioche J, Pike SJ, Tshepelevitsh S, Leito I, Morris GA, Webb SJ, et al. Conformational switching of a foldamer in a multicomponent system by pH-filtered selection between competing noncovalent interactions. J Am Chem Soc. 2015;137:6680–91. [DOI] [PubMed] [PMC]

117.

Marshall GR, Hodgkin EE, Langs DA, Smith GD, Zabrocki J, Leplawy MT. Factors governing helical preference of peptides containing multiple alpha,alpha-dialkyl amino acids. Proc Natl Acad Sci U S A. 1990;87:487–91. [DOI] [PubMed] [PMC]

118.

Banerjee R, Basu G. Short Aib/Ala-based peptide helix is as stable as an Ala-based peptide helix double its length. Chembiochem. 2002;3:1263–6. [DOI] [PubMed]

119.

Schweitzer-Stenner R, Gonzales W, Bourne GT, Feng JA, Marshall GR. Conformational manifold of α-aminoisobutyric acid (Aib) containing alanine-based tripeptides in aqueous solution explored by vibrational spectroscopy, electronic circular dichroism spectroscopy, and molecular dynamics simulations. Am Chem Soc. 2007;129:13095–109. [DOI] [PubMed]

120.

Longo E, Moretto A, Formaggio F, Toniolo C. The critical main-chain length for helix formation in water: determined in a peptide series with alternating Aib and Ala residues exclusively and detected with ECD spectroscopy. Chirality. 2011;23:756–60. [DOI] [PubMed]

121.

Pike SJ, Boddaert T, Raftery J, Webb SJ, Clayden J. Participation of non-aminoisobutyric acid (Aib) residues in the 3₁₀ helical conformation of Aib-rich foldamers: a solid state study. New J Chem. 2015;39:3288–94. [DOI]

122.

Karle IL, Kaul R, Rao RB, Raghothama S, Balaram P. Stereochemical analysis of higher α,α-dialkylglycine containing peptides. Characterization of local helical conformations at dipropylglycine residues and observation of a novel hydrated multiple β-turn structure in crystals of a glycine rich peptide. J Am Chem Soc. 1997;119:12048–54. [DOI]

123.

Karle IL, Rao RB, Prasad S, Kaul R, Balaram P. Nonstandard amino acids in conformational design of peptides. Helical structures in crystals of 5-10 residue peptides containing dipropylglycine and dibutylglycine. J Am Chem Soc. 1994;116:10355–61. [DOI]

124.

Lettieri R, Bischetti M, Gatto E, Palleschi A, Ricci E, Formaggio F, et al. Looking for the peptide 2.0₅-helix: a solvent- and main-chain length-dependent conformational switch probed by electron transfer across C^α,α-diethylglycine homo-oligomers. Biopolymers. 2013;100:51–63. [DOI] [PubMed]

125.

Oba M, Nonaka H, Doi M, Tanaka M. Conformational studies on peptides having dipropylglycine (Dpg) or 1-aminocycloheptanecarboxylic acid (Ac₇c) within the sequence of _L-leucine (Leu) residues. Biopolymers. 2016;106:210–8. [DOI] [PubMed]

126.

Benedetti E, Barone V, Bavoso A, Di Blasio B, Lelj F, Pavone V, et al. Structural versatility of peptides from C^α,α-dialkylated glycines. I. A conformational energy computation and x-ray diffraction study of homo-peptides from C^α,α-diethylglycine. Biopolymers. 1988;27:357–71. [DOI]

127.

Crisma M, Valle G, Bonora GM, Toniolo C, Lelj F, Barone V, et al. Preferred conformation of peptides from C^α,α-symmetrically disubstituted glycines: aromatic residues. Biopolymers. 1991;31:637–41. [DOI] [PubMed]

128.

Pavone V, Lombardi A, Saviano M, Di Blasio B, Nastri F, Fattorusso R, et al. Mixed conformation in C^α,α-disubstituted tripeptides: X-ray crystal structures of Z-Aib-Dph-Gly-Ome and Bz-Dph-Dph-Gly-Ome. Biopolymers. 1994;34:1595–604. [DOI] [PubMed]

129.

Gobbo M, Biondi L, Filira F, Formaggio F, Crisma M, Rocchi R, et al. Helix induction potential of N-terminal α-methyl, α-amino acids. Lett Pept Sci. 1998;5:105–7. [DOI]

130.

Welsh JH, Zerbe O, von Philipsborn W, Robinson JA. β-Turns induced in bradykinin by (S)-α-methylproline. FEBS Lett. 1992;297:216–20. [DOI] [PubMed]

131.

Polese A, Formaggio F, Crisma M, Valle G, Toniolo C, Bonora GM, et al. Peptide helices as rigid molecular rulers: a conformational study of isotactic homopeptides from α-methyl-α-isopropylglycine, [L-(αMe)Val]_n. Chemistry. 1996;2:1104–11. [DOI]

132.

Toniolo C, Crisma M, Formaggio F, Polese A, Doi M, Ishida T, et al. Effect of phenyl ring position in the C^α-methylated α-amino acid side chain on peptide preferred conformation. Pept Sci. 1996;40:523–7. [DOI]

133.

Toniolo C, Crisma M, Formaggio F, Benedetti E, Santini A, Iacovino R, et al. Preferred conformation of peptides rich in alicyclic C^α,α-disubstituted glycines. Pept Sci. 1996;40:519–22. [DOI]

134.

Maity P, König B. Enantio- and diastereoselective syntheses of cyclic C^α-tetrasubstituted α-amino acids and their use to induce stable conformations in short peptides. Biopolymers. 2008;90:8–27. [DOI] [PubMed]

135.

Demizu Y, Tanaka M, Doi M, Kurihara M, Okuda H, Suemune H. Conformations of peptides containing a chiral cyclic α, α-disubstituted α-amino acid within the sequence of Aib residues. J Pept Sci. 2010;16:621–6. [DOI] [PubMed]

136.

Demizu Y, Doi M, Kurihara M, Okuda H, Nagano M, Suemune H, et al. Conformational studies on peptides containing α,α-disubstituted α-amino acids: chiral cyclic α,α-disubstituted α-amino acid as an α-helical inducer. Org Biomol Chem. 2011;9:3303–12. [DOI] [PubMed]

137.

Byrne L, Solà J, Boddaert T, Marcelli T, Adams RW, Morris GA, et al. Foldamer-mediated remote stereocontrol: >1,60 asymmetric induction. Angew Chem Int Ed Engl. 2014;53:151–5. [DOI] [PubMed]

138.

Demizu Y, Doi M, Kurihara M, Maruyama T, Suemune H, Tanaka M. One-handed helical screw direction of homopeptide foldamer exclusively induced by cyclic α-amino acid side-chain chiral centers. Chemistry. 2012;18:2430–9. [DOI] [PubMed]

139.

Anan K, Demizu Y, Oba M, Kurihara M, Doi M, Suemune H, et al. Helical structures of bicyclic α-amino acid homochiral oligomers with the stereogenic centers at the side-chain fused-ring junctions. Helv Chim Acta. 2012;95:1694–713. [DOI]

140.

Fernández-Tejada A, Corzana F, Busto JH, Avenoza A, Peregrina JM. Stabilizing unusual conformations in small peptides and glucopeptides using a hydroxylated cyclobutane amino acid. Org Biomol Chem. 2009;7:2885–93. [DOI] [PubMed]

141.

Torrini I, Zecchini GP, Paradisi MP, Lucente G, Gavuzzo E, Mazza F, et al. Synthesis and properties of chemotactic peptide analogs. Int J Pept Protein Res. 1991;38:495–504. [DOI] [PubMed]

142.

Savrda J, Mazaleyrat JP, Wakselman M, Formaggio F, Crisma M, Toniolo C. Synthesis, conformational study, and spectroscopic characterization of the cyclic C^α,α-disubstituted glycine 9-amino-9-fluorenecarboxylic acid. J Pept Sci. 1999;5:61–74. [DOI] [PubMed]

143.

Lombardi A, De Simone G, Galdiero S, Nastri F, Di Costanzo L, Makihira K, et al. The crystal structure of Afc-containing peptides. Biopolymers. 2000;53:150–60. [DOI] [PubMed]

144.

Hirata T, Ueda A, Oba M, Doi M, Demizu Y, Kurihara M, et al. Amino equatorial effect of a six-membered ring amino acid on its peptide 3₁₀- and α-helices. Tetrahedron. 2015;71:2409–20. [DOI]

145.

Formaggio F, Crisma M, Toniolo C, Tchertanov L, Guilhem J, Mazaleyrat JP, et al. Bip: a C^α-tetrasubstituted, axially chiral α-amino acid. Synthesis and conformational preference of model peptides. Tetrahedron. 2000;56:8721–34. [DOI]

146.

Formaggio F, Peggion C, Crisma M, Toniolo C, Tchertanov L, Guilhem J, et al. A chirally stable, atropoisomeric, C^α-tetrasubstituted α-amino acid: incorporation into model peptides and conformational preference. Helv Chim Acta. 2001;84:481–501. [DOI]

147.

Mazaleyrat JP, Wright K, Gaucher A, Toulemonde N, Wakselman M, Oancea S, et al. Induced axial chirality in the biphenyl core of the C^α-tetrasubstituted α-amino acid residue Bip and subsequent propagation of chirality in (Bip)_n/Val oligopeptides. J Am Chem Soc. 2004;126:12874–9. [DOI] [PubMed]

148.

Crisma M, Toniolo C. Helical screw-sense preferences of peptides based on chiral, C^α-tetrasubstituted α-amino acids. Pept Sci. 2015;104:46–64. [DOI] [PubMed]

149.

Morera E, Lucente G, Ortar G, Nalli M, Mazza F, Gavuzzo E, et al. Exploring the interest of 1,2-dithiolane ring system in peptide chemistry. Synthesis of a chemotactic tripeptide and x-ray crystal structure of a 4-amino-1,2-dithiolane-4-carboxylic acid derivative. Bioorg Med Chem. 2002;10:147–57. [DOI] [PubMed]

150.

Aschi M, Lucente G, Mazza F, Mollica A, Morera E, Nalli M, et al. Peptide backbone folding induced by the C^α-tetrasubstituted cyclic α-amino acids 4-amino-1,2-dithiolane-4-carboxylic acid (Adt) and 1-aminocyclopentane-1-carboxylic acid (Ac₅c). A joint computational and experimental study. Org Biomol Chem. 2003;1:1980–8. [DOI] [PubMed]

151.

Morera E, Nalli M, Mollica A, Paradisi MP, Aschi M, Gavuzzo E, et al. Peptides containing 4-amino-1,2-dithiolane-4-carboxylic acid (Adt): conformation of Boc-Adt-Adt-NHMe and NH^…S interactions. J Pept Sci. 2005;11:104–12. [DOI] [PubMed]

152.

Maity P, Zabel M, König B. Tetrahydrofuran Cα-tetrasubstituted amino acids: two consecutive β-turns in a crystalline linear tripeptide. J Org Chem. 2007;72:8046–53. [DOI] [PubMed]

153.

Grauer AA, Cabrele C, Zabel M, König B. Stable right- and left-handed peptide helices containing C^α-tetrasubstituted α-amino acids. J Org Chem. 2009;74:3718–26. [DOI] [PubMed]

154.

Strässler C, Linden A, Heimgartner H. Novel heterospirocyclic 3-amino-2H-azirines as synthons for heterocyclic α-amino acids. Helv Chim Acta. 1997;80:1528–54. [DOI]

155.

Torrini I, Zecchini GP, Paradisi MP, Lucente G, Gavuzzo F, Mazza F, et al. Modified chemotactic peptides: synthesis, conformation, and biological activity of for-Thp-Leu-Δ^zPhe-OMe. Biopolymers. 1994;34:1291–302. [DOI] [PubMed]

156.

Stoykova SA, Linden A, Heimgartner H. Highly constrained linear oligopeptides containing heterocyclic α-amino carboxylic acids. Helv Chim Acta. 2013;96:1714–32. [DOI]

157.

Yokum TS, Gauthier TJ, Hammer RP, McLaughlin ML. Solvent effects on the 3₁₀-/α-helix equilibrium in short amphipathic peptides rich in α,α-disubstituted amino acids. J Am Chem Soc. 1997;119:1167–8. [DOI]

158.

Yokum TS, Bursavich MG, Gauthier T, Hammer RP, McLaughlin ML. 3₁₀-Helix stabilization via side-chain salt bridges¹. Chem Commun. 1998:1801–2. [DOI]

159.

Ousaka N, Tani N, Sekiya R, Kuroda R. Decelerated chirality interconversion of an optically inactive 3₁₀-helical peptide by metal chelation. Chem Commun. 2008:2894–6. [DOI] [PubMed]

160.

Ousaka N, Sato T, Kuroda R. Intramolecular crosslinking of an optically inactive 3₁₀-helical peptide: stabilization of structure and helix sense. J Am Chem Soc. 2008;130:463–5. [DOI] [PubMed]

161.

Ousaka N, Sato T, Kuroda R. Total helical-sense bias of an achiral peptide main chain induced by a chiral side-chain bridge. J Am Chem Soc. 2009;131:3820–1. [DOI] [PubMed]

162.

Hanson P, Millhauser G, Formaggio F, Crisma M, Toniolo C. ESR characterization of hexameric, helical peptides using double TOAC spin labeling. J Am Chem Soc. 1996;118:7618–25. [DOI]

163.

Hanson P, Martinez G, Millhauser G, Formaggio F, Crisma M, Toniolo C, et al. Distinguishing helix conformations in alanine-rich peptides using the unnatural amino acid TOAC and electron spin resonance. J Am Chem Soc. 1996;118:271–2. [DOI]

164.

Schreier S, Bozelli JC Jr, Marin N, Vieira RF, Nakaie CR. The spin label amino acid TOAC and its uses in studies of peptides: chemical, physicochemical, spectroscopic, and conformational aspects. Biophys Rev. 2012;4:45–66. [DOI] [PubMed] [PMC]

165.

Smythe ML, Nakaie CR, Marshall GR. α-Helical versus 3₁₀-helical conformation of alanine-based peptides in aqueous solution: an electron spin resonance investigation. J Am Chem Soc. 1995;117:10555–62. [DOI]

166.

Crisma M, Deschamps JR, George C, Flippen-Anderson JL, Kaptein B, Broxterman QB, et al. A topographically and conformationally constrained, spin-labeled, α-amino acid: crystallographic characterization in peptides. J Pept Res. 2005;65:564–79. [DOI] [PubMed]

167.

Ruffoni A, Contini A, Soave R, Lo Presti L, Esposto I, Maffucci I, et al. Model peptides containing the 3-sulfanyl-norbornene amino acid, a conformationally constrained cysteine analogue effective inducer of 3₁₀-helix secondary structures. RSC Adv. 2015;5:32643–56. [DOI]

168.

Núñez-Villanueva D, Infantes L, García-López MT, González-Muñiz R, Martín-Martínez M. Azepane quaternary amino acids as effective inducers of 3₁₀ helix conformations. J Org Chem. 2012;77:9833–9. [DOI] [PubMed]

169.

Núñez-Villanueva D, Plata-Ruiz A, Romero-Muñiz I, Martín-Pérez I, Infantes L, González-Muñiz R, et al. β-Turn induction by a diastereopure azepane-derived quaternary amino acid. J Org Chem. 2023;88:14688–96. [DOI] [PubMed] [PMC]

170.

Núñez-Villanueva D, Bonache MA, Infantes L, García-López MT, Martín-Martínez M, González-Muñiz R. Quaternary α,α-2-oxoazepane α-amino acids: synthesis from ornithine-derived β-lactams and incorporation into model dipeptides. J Org Chem. 2011;76:6592–603. [DOI] [PubMed]

171.

Tomasini C, Luppi G, Monari M. Oxazolidin-2-one-containing pseudopeptides that fold into β-bend ribbon spirals. J Am Chem Soc. 2006;128:2410–20. [DOI] [PubMed]

172.

Rajashankar KR, Ramakumar S, Chauhan VS. Design of α helical motif using α,β-dehydrophenylalanine residues: crystal structure of Boc-Val-ΔPhe-Phe-Ala-Phe-ΔPhe-Val-ΔPhe-Gly-OCH₃, a 3₁₀-helical nonapeptide. J Am Chem Soc. 1992;114:9225–6. [DOI]

173.

Pieroni O, Fissi A, Jain RM, Chauhan VS. Solution structure of dehydropeptides: a CD investigation. Biopolymers. 1996;38:97–108. [DOI] [PubMed]

174.

Jain RM, Rajashankar KR, Ramakumar S, Chauhan VS. First observation of left-handed helical conformation in a dehydro peptide containing two _L-Val residues. Crystal and solution structure of Boc-_L-Val-ΔPhe-ΔPhe-ΔPhe-_L-Val-OMe. J Am Chem Soc. 1997;119:3205–11. [DOI]

175.

Demizu Y, Yamagata N, Sato Y, Doi M, Tanaka M, Okuda H, et al. Controlling the helical screw sense of peptides with C-terminal L-valine. J Pept Sci. 2010;16:153–8. [DOI] [PubMed]

176.

Dutta MG, Mathur P, Chauhan VS. De novo design, synthesis and solution conformational study of two didehydroundecapeptides: effect of nature and number of amino acids interspersed between Phe residues. J Pept Sci. 2011;17:783–90. [DOI] [PubMed]

177.

Gupta M, Chauhan VS. De novo design of α,β-didehydrophenylalanine containing peptides: from models to applications. Biopolymers. 2011;95:161–73. [DOI] [PubMed]

178.

Buczek A, Makowski M, Jewgiński M, Latajka R, Kupka T, Broda MA. Toward engineering efficient peptidomimetics. Screening conformational landscape of two modified dehydroaminoacids. Biopolymers. 2014;101:28–40. [DOI] [PubMed]

179.

Joaquin D, Lee MA, Kastner DW, Singh J, Morrill ST, Damstedt G, et al. Impact of dehydroamino acids on the structure and stability of incipient 3₁₀-helical peptides. J Org Chem. 2020;85:1601–13. [DOI] [PubMed] [PMC]

180.

Ohyama T, Oku H, Hiroki A, Maekawa Y, Yoshida M, Katakai R. The crystal structure for a depsipeptide Boc–(Leu–Leu–Ala)₂–(Leu–Leu–Lac)₃–OEt with a 3₁₀-helical segment. Biopolymers. 2000;54:375–8. [DOI]

181.

Cheng RP, Gellman SH, DeGrado WF. β-Peptides: from structure to function. Chem Rev. 2001;101:3219–32. [DOI] [PubMed]

182.

Choi SH, Guzei IA, Spencer LC, Gellman SH. Crystallographic characterization of helical secondary structures in 2:1 and 1:2 α/β-peptides. J Am Chem Soc. 2009;131:2917–24. [DOI] [PubMed]

183.

Choi SH, Guzei IA, Spencer LC, Gellman SH. Crystallographic characterization of helical secondary structures in α/β-peptides with 1:1 residue alternation. J Am Chem Soc. 2008;130:6544–50. [DOI] [PubMed]

184.

Choi SH, Guzei IA, Spencer LC, Gellman SH. Crystallographic characterization of 12-helical secondary structure in β-peptides containing side chain groups. J Am Chem Soc. 2010;132:13879–85. Erratum in: J Am Chem Soc. 2010;132:15456. [DOI] [PubMed] [PMC]

185.

Jadhav SV, Bandyopadhyay A, Gopi HN. Protein secondary structure mimetics: crystal conformations of α/γ⁴-hybrid peptide 12-helices with proteinogenic side chains and their analogy with α- and β-peptide helices. Org Biomol Chem. 2013;11:509–14. [DOI] [PubMed]

186.

Mathieu L, Legrand B, Deng C, Vezenkov L, Wenger E, Didierjean C, et al. Helical oligomers of thiazole-based γ-amino acids: synthesis and structural studies. Angew Chem Int Ed Engl. 2013;52:6006–10. [DOI] [PubMed]

187.

Skowron KJ, Speltz TE, Moore TW. Recent structural advances in constrained helical peptides. Med Res Rev. 2019;39:749–70. [DOI] [PubMed] [PMC]

188.

Lau YH, de Andrade P, Wu Y, Spring DR. Peptide stapling techniques based on different macrocyclisation chemistries. Chem Soc Rev. 2015;44:91–102. [DOI] [PubMed]

189.

Schievano E, Bisello A, Chorev M, Bisol A, Mammi S, Peggion E. Aib-rich peptides containing lactam-bridged side chains as models of the 3₁₀-helix. J Am Chem Soc. 2001;123:2743–51. [DOI] [PubMed]

190.

Schievano E, Pagano K, Mammi S, Peggion E. Conformational studies of Aib-rich peptides containing lactam-bridged side chains: evidence of 3₁₀-helix formation. Biopolymers. 2005;80:294–302. [DOI] [PubMed]

191.

Boal AK, Guryanov I, Moretto A, Crisma M, Lanni EL, Toniolo C, et al. Facile and E-selective intramolecular ring-closing metathesis reactions in 3₁₀-helical peptides: a 3D structural study. J Am Chem Soc. 2007;129:6986–7. [DOI] [PubMed]

192.

Blackwell HE, Sadowsky JD, Howard RJ, Sampson JN, Chao JA, Steinmetz WE, et al. Ring-closing metathesis of olefinic peptides: design, synthesis, and structural characterization of macrocyclic helical peptides. J Org Chem. 2001;66:5291–302. [DOI] [PubMed]

193.

Jacobsen Ø, Maekawa H, Ge NH, Görbitz CH, Rongved P, Ottersen OP, et al. Stapling of a 3₁₀-helix with click chemistry. J Org Chem. 2011;76:1228–38. [DOI]

194.

Patgiri A, Jochim AL, Arora PS. A hydrogen bond surrogate approach for stabilization of short peptide sequences in α-helical conformation. Acc Chem Res. 2008;41:1289–300. [DOI] [PubMed] [PMC]

195.

Pal S, Prabhakaran EN. Hydrogen bond surrogate stabilized water soluble 3₁₀-helix from a disordered pentapeptide containing coded α-amino acids. Tetrahedron Lett. 2018;59:2515–9. [DOI]

196.

Banerji B, Mallesham B, Kumar SK, Kunwar AC, Iqbal J. Synthesis of a cyclic pseudo 3₁₀ helical structure from a β-amino acid-_L-proline derived tripeptide via a ring closing metathesis reaction. Tetrahedron Lett. 2002;43:6479–83. [DOI]

197.

Wegener KL, McGrath AE, Dixon NE, Oakley AJ, Scanlon DB, Abell AD, et al. Rational design of a 3₁₀-helical PIP-box mimetic targeting PCNA, the human sliding clamp. Chemistry. 2018;24:11325–31. [DOI] [PubMed]

198.

Heinis C, Rutherford T, Freund S, Winter G. Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat Chem Biol. 2009;5:502–7. [DOI] [PubMed]

199.

Mudd GE, Brown A, Chen L, van Rietschoten K, Watcham S, Teufel DP, et al. Identification and optimization of EphA2-selective bicycles for the delivery of cytotoxic payloads. J Med Chem. 2020;63:4107–16. [DOI] [PubMed]

200.

Kaffy J, Berardet C, Mathieu L, Legrand B, Taverna M, Halgand F, et al. Helical γ-peptide foldamers as dual inhibitors of amyloid-β peptide and islet amyloid polypeptide oligomerization and fibrillization. Chemistry. 2020;26:14612–22. [DOI] [PubMed]

201.

D’Addona D, Carotenuto A, Novellino E, Piccand V, Reubi JC, Di Cianni A, et al. Novel sst₅-selective somatostatin dicarba-analogues: synthesis and conformation–affinity relationships. J Med Chem. 2008;51:512–20. [DOI] [PubMed]

202.

Jones JE, Diemer V, Adam C, Raftery J, Ruscoe RE, Sengel JT, et al. Length-dependent formation of transmembrane pores by 3₁₀-helical α-aminoisobutyric acid foldamers. J Am Chem Soc. 2016;138:688–95. [DOI] [PubMed] [PMC]

203.

Pike SJ, Jones JE, Raftery J, Clayden J, Webb SJ. Helical peptaibol mimics are better ionophores when racemic than when enantiopure. Org Biomol Chem. 2015;13:9580–4. [DOI] [PubMed]

204.

Lizio MG, Campana M, De Poli M, Jefferies DF, Cullen W, Andrushchenko V, et al. Insight into the mechanism of action and peptide-membrane interactions of Aib-rich peptides: multitechnique experimental and theoretical analysis. Chembiochem. 2021;22:1656–67. [DOI] [PubMed] [PMC]

205.

Metrano AJ, Chinn AJ, Shugrue CR, Stone EA, Kim B, Miller SJ. Asymmetric catalysis mediated by synthetic peptides, version 2.0: expansion of scope and mechanisms. Chem Rev. 2020;120:11479–615. [DOI] [PubMed] [PMC]

206.

Metrano AJ, Miller SJ. Peptide-based catalysts reach the outer sphere through remote desymmetrization and atroposelectivity. Acc Chem Res. 2019;52:199–215. [DOI] [PubMed] [PMC]

207.

Rossi P, Felluga F, Tecilla P, Formaggio F, Crisma M, Toniolo C, et al. A bimetallic helical heptapeptide as a transphosphorylation catalyst in water. J Am Chem Soc. 1999;121:6948–9. [DOI]

208.

Sissi C, Rossi P, Felluga F, Formaggio F, Palumbo M, Tecilla P, et al. Dinuclear Zn²⁺ complexes of synthetic heptapeptides as artificial nucleases. J Am Chem Soc. 2001;123:3169–70. [DOI] [PubMed]

209.

Scarso A, Scheffer U, Göbel M, Broxterman QB, Kaptein B, Formaggio F, et al. A peptide template as an allosteric supramolecular catalyst for the cleavage of phosphate esters. Proc Natl Acad Sci U S A. 2002;99:5144–9. [DOI] [PubMed] [PMC]

210.

Demizu Y, Yamagata N, Nagoya S, Sato Y, Doi M, Tanaka M, et al. Enantioselective epoxidation of α,β-unsaturated ketones catalyzed by stapled helical _L-Leu-based peptides. Tetrahedron. 2011;67:6155–65. [DOI]

211.

Geller T, Gerlach A, Krüger CM, Militzer HC. The Juliá-Colonna epoxidation: access to chiral, non-racemic epoxides. J Mol Catal A Chem. 2006;251:71–7. [DOI]

212.

Weyer A, Díaz D, Nierth A, Schlörer NE, Berkessel A. The L-Leu hexamer, a short and highly enantioselective peptide catalyst for the Juliá–Colonna epoxidation: stabilization of a helical conformation in DMSO. ChemCatChem. 2012;4:337–40. [DOI]

213.

Girvin ZC, Andrews MK, Liu X, Gellman SH. Foldamer-templated catalysis of macrocycle formation. Science. 2019;366:1528–31. [DOI] [PubMed] [PMC]

214.

Ghosh S, Tran PN, McElheny D, Perez JJ, Nguyen AI. Peptidic scaffolds enable rapid and multivariate secondary sphere evolution for an abiotic metallocatalyst. Inorg Chem. 2022;61:6679–87. [DOI] [PubMed]

215.

Bianco A, Gasparrini F, Maggini M, Misiti D, Polese A, Prato M, et al. Molecular recognition by a silica-bound fullerene derivative. J Am Chem Soc. 1997;119:7550–4. [DOI]

216.

Bianco A, Corvaja C, Crisma M, Guldi DM, Maggini M, Sartori E, et al. A helical peptide receptor for [60]fullerene. Chemistry. 2002;8:1544–53. [DOI] [PubMed]

217.

Solà J, Fletcher SP, Castellanos A, Clayden J. Nanometer-range communication of stereochemical information by reversible switching of molecular helicity. Angew Chem Int Ed Engl. 2010;49:6836–9. [DOI] [PubMed]

218.

De Poli M, Zawodny W, Quinonero O, Lorch M, Webb SJ, Clayden J. Conformational photoswitching of a synthetic peptide foldamer bound within a phospholipid bilayer. Science. 2016;352:575–80. [DOI] [PubMed]

219.

Lister FGA, Le Bailly BAF, Webb SJ, Clayden J. Ligand-modulated conformational switching in a fully synthetic membrane-bound receptor. Nat Chem. 2017;9:420–5. [DOI]

220.

Pengo P, Broxterman QB, Kaptein B, Pasquato L, Scrimin P. Synthesis of a stable helical peptide and grafting on gold nanoparticles. Langmuir. 2003;19:2521–4. [DOI]

221.

Fabris L, Antonello S, Armelao L, Donkers RL, Polo F, Toniolo C, et al. Gold nanoclusters protected by conformationally constrained peptides. J Am Chem Soc. 2006;128:326–36. [DOI] [PubMed]